Gilead: Upside From Potential Coronavirus Treatment Could Dissipate [Seeking Alpha]
GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
US:NYSE Investor Relations:
gsk.com/en-gb/investors
Company Research
Source: Seeking Alpha
SummaryIn February, GILD divulged it was providing remdesivir to coronavirus patients on an emergency basis.GILD is up by double digits since then. The upside could dissipate until remdesivir is formally approved by the FDA.GILD has few other catalysts besides HIV drug Biktarvy. GILD remains a hold.Source: New York TimesGilead (expanded accessGilead Sciences (GILD)has been workingSuch programs allow hospitals or physicians to apply for emergency use of the treatment for multiple severely ill patients at a time.Even though the medicine isn't yet approved for use by any regulatory authorities, Gilead is taking the step of expanding production to increase supply.Gilead has sharply reduced remdesivir's production timeline from one year to about six months. There are several drug candidates that could potentially vie with remdesivir to treat coronavirus. The question remains, "can they be produced in large enough quantities to make a difference." In expanding production capacity, Gilead ap
Show less
Read more
Impact Snapshot
Event Time:
GSK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GSK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GSK alerts
High impacting GSK plc American Depositary Shares (Each representing two Ordinary Shares) news events
Weekly update
A roundup of the hottest topics
GSK
News
- BioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 MillionGlobeNewswire
- GSK Trades At Low Price Multiples, But Its Pipeline Needs To Improve [Seeking Alpha]Seeking Alpha
- 12 Best Biotech Penny Stocks to Invest In [Yahoo! Finance]Yahoo! Finance
- Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancerBusiness Wire
- GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising RiseBusiness Wire
GSK
Sec Filings
- 5/3/24 - Form 6-K
- 5/1/24 - Form 6-K
- 5/1/24 - Form 6-K
- GSK's page on the SEC website